Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Reprimands Snake Venom Seller For Pain Claims Amid Opioid Crisis

Mar 20 2019

• By Eileen Francis

Vintage inscription made by old typewriter, warning

Related Content

Opioid Treatment Claims Linked To Depression Drug Found In Supplements

Nov 21 2018

In Brief

Jan 09 2012

US FDA Moves Homeopathic Drug Enforcement To Risk-Based Approach

Dec 19 2017

OTC Homeopathic Market Could Shrink Under US FDA Risk-Based Oversight, Trade Groups Say

Jun 28 2018

OTC Homeopathy Group Revises Label Disclaimers In Light Of FTC Scrutiny

Jun 28 2018

FDA Turns Kratom's Future In US Dietary Supplement Market Into History

Nov 15 2017

Additional Topics

United States Advertising, Marketing & Sales Commercial Companies Dietary Supplements E-Commerce FDA Enforcement Regulation Consumer

More from Marketing & Advertising

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window